MITRAL ANNULAR DISJUNCTION IN ATHLETES: AN UNDERRECOGNIZED ARRHYTHMOGENIC SUBSTRATE AT THE INTERFACE OF SPORTS CARDIOLOGY AND SUDDEN CARDIAC DEATH PREVENTION
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6426Keywords:
Mitral Annular Disjunction; Mitral Valve Prolapse; Sports Cardiology; Ventricular Arrhythmia; Sudden Cardiac Death; Athlete's HeartAbstract
Background: Mitral annular disjunction (MAD) is a structural abnormality of the mitral valve apparatus characterized by atrial displacement of the leaflet hinge point away from the left ventricular myocardium. Once considered an incidental finding, MAD is now recognized as a component of the arrhythmic mitral valve prolapse phenotype and a potential substrate for ventricular arrhythmias and sudden cardiac death, particularly in physically active individuals.
Objectives: To summarize current evidence regarding the anatomy, epidemiology, arrhythmogenic mechanisms, multimodality imaging, risk stratification, and management of MAD, with emphasis on its relevance in athletes.
Methods: A narrative review of the literature was performed using PubMed/MEDLINE and major cardiology and sports medicine journals. Publications from 1999 to 2024 were reviewed using the terms “mitral annular disjunction”, “arrhythmic mitral valve prolapse”, “athlete”, “exercise”, “sudden cardiac death”, “eligibility”, and “return to play”. Priority was given to recent guidelines, expert consensus documents, systematic reviews, large cohort studies, and landmark publications.
Results: Physiological cardiac remodeling in athletes may obscure the diagnosis of MAD, while exercise-related hemodynamic and autonomic changes may facilitate ventricular arrhythmias in susceptible individuals. Current recommendations support individualized risk assessment and shared decision-making rather than universal sports restriction.
Conclusions: MAD should be considered during cardiovascular evaluation of athletes with bileaflet mitral valve prolapse, unexplained ventricular arrhythmias, or a family history of sudden cardiac death. Further studies are needed to establish athlete-specific risk stratification and long-term management strategies.
References
Dejgaard, L. A., Skjølsvik, E. T., Lie, Ø. H., Ribe, M., Stokke, M. K., Hegbom, F., Scheirlynck, E. S., Gjertsen, E., Andresen, K., Helle-Valle, T. M., Hopp, E., Edvardsen, T., & Haugaa, K. H. (2018). The ome. Journal of the American College of Cardiology, 72(14), 1600–1609. https://doi.org/10.1016/j.jacc.2018.07.070
Basso, C., Perazzolo Marra, M., Rizzo, S., De Lazzari, M., Giorgi, B., Cipriani, A., Frigo, A. C., Rigato, I., Migliore, F., Pilichou, K., Bertaglia, E., Cacciavillani, L., Bauce, B., Corrado, D., Thiene, G., & Iliceto, S. (2015). Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation, 132(7), 556–566. https://doi.org/10.1161/CIRCULATIONAHA.115.016291
Miller, M. A., Dukkipati, S. R., Turagam, M., Liao, S. L., Adams, D. H., & Reddy, V. Y. (2018). Arrhythmic mitral valve prolapse: JACC review topic of the week. Journal of the American College of Cardiology, 72(23 Pt A), 2904–2914. https://doi.org/10.1016/j.jacc.2018.09.048
Essayagh, B., Sabbag, A., Antoine, C., Benfari, G., Yang, L.-T., Maalouf, J., Asirvatham, S., Michelena, H., & Enriquez-Sarano, M. (2020). Presentation and outcome of arrhythmic mitral valve prolapse. Journal of the American College of Cardiology, 76(6), 637–649. https://doi.org/10.1016/j.jacc.2020.06.029
Niarchou, P., Prappa, E., Liatakis, I., Vlachos, K., Chatziantoniou, A., Nyktari, E., Tse, G., Efremidis, M., & Letsas, K. P. (2022). Mitral valve prolapse and mitral annular disjunction arrhythmic syndromes: Diagnosis, risk stratification and management. Reviews in Cardiovascular Medicine, 23(9), 295. https://doi.org/10.31083/j.rcm2309295
Essayagh, B., Sabbag, A., Antoine, C., Benfari, G., Batista, R., Yang, L.-T., Maalouf, J., Thapa, P., Asirvatham, S., Michelena, H. I., & Enriquez-Sarano, M. (2021). The mitral annular disjunction of mitral valve prolapse: Presentation and outcome. JACC: Cardiovascular Imaging, 14(11), 2073–2087. https://doi.org/10.1016/j.jcmg.2021.04.029
Chakrabarti, A. K., Bogun, F., & Liang, J. J. (2022). Arrhythmic mitral valve prolapse and mitral annular disjunction: Clinical features, pathophysiology, risk stratification, and management. Journal of Cardiovascular Development and Disease, 9(2), 61. https://doi.org/10.3390/jcdd9020061
Han, H.-C., Calafiore, P., Teh, A. W., Farouque, O., & Lim, H. S. (2019). Arrhythmic mitral annulus disjunction and mitral valve prolapse: Components of the same clinical spectrum? Journal of the American College of Cardiology, 73(6), 739. https://doi.org/10.1016/j.jacc.2018.10.090
Freed, L. A., Levy, D., Levine, R. A., Larson, M. G., Evans, J. C., Fuller, D. L., Lehman, B., & Benjamin, E. J. (1999). Prevalence and clinical outcome of mitral-valve prolapse. The New England Journal of Medicine, 341(1), 1–7. https://doi.org/10.1056/NEJM199907013410101
Vriz, O., Landi, I., Eltayeb, A., Limongelli, G., Mos, L., Delise, P., Bossone, E., & D’Andrea, A. (2023). Mitral valve prolapse and sudden cardiac death in athletes at high risk. Current Cardiology Reviews, 19(3), e201222212066. https://doi.org/10.2174/1573403X19666221220163431
Maron, B. J., & Pelliccia, A. (2006). The heart of trained athletes: Cardiac remodeling and the risks of sports, including sudden death. Circulation, 114(15), 1633–1644. https://doi.org/10.1161/CIRCULATIONAHA.106.613562
Corrigendum to: 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. (2021). European Heart Journal, 42(5), 548–549. https://doi.org/10.1093/eurheartj/ehaa835
Aabel, E. W., Chivulescu, M., Lie, Ø. H., Hopp, E., Gjertsen, E., Ribe, M., Helle-Valle, T. M., Edvardsen, T., Hegbom, F., Dejgaard, L. A., & Haugaa, K. H. (2023). Ventricular arrhythmias in arrhythmic mitral valve syndrome—A prospective continuous long-term cardiac monitoring study. Europace, 25(2), 506–516. https://doi.org/10.1093/europace/euac182
Hourdain, J., Clavel, M. A., Deharo, J.-C., Asirvatham, S., Avierinos, J. F., Habib, G., Franceschi, F., Probst, V., Sadoul, N., Martins, R., Leclercq, C., Chauvin, M., Pasquie, J. L., Maury, P., Laurent, G., Ackerman, M., Hodge, D. O., & Enriquez-Sarano, M. (2018). Common phenotype in patients with mitral valve prolapse who experienced sudden cardiac death. Circulation, 138(10), 1067–1069. https://doi.org/10.1161/CIRCULATIONAHA.118.033488
Sriram, C. S., Syed, F. F., Ferguson, M. E., Johnson, J. N., Enriquez-Sarano, M., Cetta, F., Cannon, B. C., Asirvatham, S. J., & Ackerman, M. J. (2013). Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. Journal of the American College of Cardiology, 62(3), 222–230. https://doi.org/10.1016/j.jacc.2013.02.060
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., James, C. A., Kim, J. H., Krahn, A. D., La Gerche, A., Link, M. S., MacIntyre, C., Mont, L., Salerno, J. C., & Shah, M. J. (2024). 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play. Heart Rhythm, 21(10), e151–e252. https://doi.org/10.1016/j.hrthm.2024.05.018
Five, C. K., Hasselberg, N. E., Aaserud, L. T., Castrini, A. I., Vlaisavljevic, K., Lie, Ø., Rootwelt-Norberg, C., Aabel, E. W., & Haugaa, K. H. (2023). Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse. Europace, 25(10), euad309. https://doi.org/10.1093/europace/euad309
Vaksmann, G., Bouzguenda, I., Guillaume, M.-P., Gras, P., Silvestri, V., & Richard, A. (2023). Mitral annular disjunction and Pickelhaube sign in children with mitral valve prolapse: A prospective cohort study. Archives of Cardiovascular Diseases, 116(11), 514–522. https://doi.org/10.1016/j.acvd.2023.08.004
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Maja Śmigielska, Agnieszka Nowosielska-Ogórek, Julia Strumińska-Szularz, Sylwia Janczak, Tymoteusz Węgrzyn
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
